Ophthalmic Drug Delivery157

Issue No #157 Mar 2024 March 16th, 2024

Inside the magazine

ADDRESSING INTRAVITREAL PRODUCT MANUFACTURING AND DEVELOPMENT CHALLENGES

Dr Andrea Allmendinger

ADDRESSING INTRAVITREAL PRODUCT MANUFACTURING AND DEVELOPMENT CHALLENGES

Andrea Allmendinger, Hanns-Christian Mahler and Philipp Behrendt discuss the challenges of filling very small volumes into syringes for intravitreal injections, and how ten23’s innovative filling technology can help combat the critical issue of air bubble formation.

INTERVIEW: UNITHER PHARMACEUTICALS’ INNOVATIVE APPROACH TO OPHTHALMIC MANUFACTURING

Unither Pharmaceuticals

INTERVIEW: UNITHER PHARMACEUTICALS’ INNOVATIVE APPROACH TO OPHTHALMIC MANUFACTURING

Natalia Servol shares insights into Unither Pharmaceutical’s preservative-free multidose technology. With a focus on addressing patient needs and meeting industry demands, the company offers a distinctive approach to sterile manufacturing in the ophthalmic sector.

COMPARATIVE USABILITY STUDY OF MULTIDOSE PRESERVATIVE-FREE EYE DROP DEVICES

COMPARATIVE USABILITY STUDY OF MULTIDOSE PRESERVATIVE-FREE EYE DROP DEVICES

Rouven Kraus discusses the results of a study investigating dose accuracy and reproducibility, along with user preferences, for a variety of multidose preservative-free eye drop devices.

LISTENING TO THE PATIENT’S VOICE TO IMPROVE EYE CARE

LISTENING TO THE PATIENT’S VOICE TO IMPROVE EYE CARE

Zoë Davidson discusses the benefits of collaborating with patients to improve eye care management.

ACCURATE DELIVERY & PRECISE DOSING OF EYE DROPS: WHAT IF WE CHANGE THE INSTILLATION PROCEDURE?

Dr Philippe Daull

Akrivision Technologies

ACCURATE DELIVERY & PRECISE DOSING OF EYE DROPS: WHAT IF WE CHANGE THE INSTILLATION PROCEDURE?

Philippe Daull and Pierre Roy discuss how changing the administration procedure for eye drops can improve the patient experience and eliminate health risks.

Top